Campbell & CO Investment Adviser LLC Invests $2.09 Million in Plexus Corp. $PLXS

Key Points

• Campbell & CO Investment Adviser LLC has acquired 16,293 shares of Plexus Corp., worth approximately $2,088,000, representing about 0.06% ownership in the company.
• Plexus Corp. reported $1.90 earnings per share (EPS) for the last quarter, exceeding analyst expectations and marking a 6.0% increase in revenue year-over-year.
• Recent analysts' evaluations of Plexus show a mixed sentiment, with a current average rating of "Moderate Buy" and a price target of $152.00.

Campbell & CO Investment Adviser LLC purchased a new position in shares of Plexus Corp. (NASDAQ:PLXS - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 16,293 shares of the technology company's stock, valued at approximately $2,088,000. Campbell & CO Investment Adviser LLC owned 0.06% of Plexus as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the stock. Xponance Inc. raised its holdings in shares of Plexus by 4.8% during the 1st quarter. Xponance Inc. now owns 2,315 shares of the technology company's stock worth $297,000 after acquiring an additional 106 shares during the period. Aquatic Capital Management LLC increased its position in shares of Plexus by 134.0% during the 4th quarter. Aquatic Capital Management LLC now owns 234 shares of the technology company's stock worth $37,000 after purchasing an additional 134 shares during the last quarter. Fox Run Management L.L.C. increased its position in shares of Plexus by 7.2% during the 1st quarter. Fox Run Management L.L.C. now owns 2,017 shares of the technology company's stock worth $258,000 after purchasing an additional 135 shares during the last quarter. Squarepoint Ops LLC increased its position in shares of Plexus by 1.1% during the 4th quarter. Squarepoint Ops LLC now owns 13,846 shares of the technology company's stock worth $2,167,000 after purchasing an additional 148 shares during the last quarter. Finally, Nisa Investment Advisors LLC increased its position in shares of Plexus by 1.6% during the 1st quarter. Nisa Investment Advisors LLC now owns 12,773 shares of the technology company's stock worth $1,637,000 after purchasing an additional 205 shares during the last quarter. Hedge funds and other institutional investors own 94.45% of the company's stock.

Insider Buying and Selling at Plexus

In other news, insider Michael J. Running sold 646 shares of the business's stock in a transaction dated Friday, May 30th. The stock was sold at an average price of $130.05, for a total transaction of $84,012.30. Following the completion of the transaction, the insider directly owned 630 shares of the company's stock, valued at approximately $81,931.50. The trade was a 50.63% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Patrick John Jermain sold 2,178 shares of the business's stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $130.42, for a total value of $284,054.76. Following the transaction, the chief financial officer directly owned 23,459 shares of the company's stock, valued at approximately $3,059,522.78. This represents a 8.50% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 10,002 shares of company stock valued at $1,308,007. 1.76% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on PLXS. Benchmark reissued a "buy" rating and set a $160.00 price objective on shares of Plexus in a research report on Wednesday, June 4th. Needham & Company LLC cut their price objective on Plexus from $162.00 to $158.00 and set a "buy" rating for the company in a research report on Thursday, July 24th. Wall Street Zen downgraded Plexus from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 16th. Stifel Nicolaus set a $140.00 price objective on Plexus in a research report on Thursday, July 24th. Finally, Sidoti raised Plexus from a "neutral" rating to a "buy" rating and raised their price objective for the stock from $135.00 to $150.00 in a research report on Friday, July 25th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $152.00.

Plexus Trading Up 0.7%

NASDAQ PLXS traded up $1.00 during trading on Thursday, hitting $139.62. The stock had a trading volume of 110,705 shares, compared to its average volume of 178,515. The company has a market capitalization of $3.77 billion, a PE ratio of 23.79 and a beta of 0.80. The company has a quick ratio of 0.74, a current ratio of 1.58 and a debt-to-equity ratio of 0.06. The firm has a 50 day moving average price of $132.83 and a 200 day moving average price of $130.06. Plexus Corp. has a twelve month low of $103.43 and a twelve month high of $172.89.

Plexus (NASDAQ:PLXS - Get Free Report) last released its earnings results on Wednesday, July 23rd. The technology company reported $1.90 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.19. The company had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.02 billion. Plexus had a return on equity of 12.33% and a net margin of 4.04%.Plexus's revenue was up 6.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.45 EPS. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. As a group, equities research analysts forecast that Plexus Corp. will post 5.9 earnings per share for the current year.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.